Clinical Trials Logo

Filter by:
NCT ID: NCT01137682 Completed - Acromegaly Clinical Trials

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

PAOLA
Start date: July 19, 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of pasireotide LAR 40 and 60 mg versus octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly.

NCT ID: NCT01136551 Not yet recruiting - Healthy Clinical Trials

Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A

Start date: September 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to develop oral controlled release formulation of Huperzine A that will provide optimal pharmacokinetic profile of the drug enhancing safety and compliance, as possible cure to neurodegenerative disorders.

NCT ID: NCT01136473 Completed - Congenital Cataract Clinical Trials

Mechanism of Aphakic and Pseudophakic Glaucoma in Pediatric Patients

Start date: July 2011
Phase: N/A
Study type: Observational

In cell cultures, lens epithelial cells and trabecular meshwork cells will be exposed to aqueous humor from pediatric eyes undergoing cataract removal surgery. Cytokine analysis of candidate factors will be performed before and after exposure to lens epithelial.

NCT ID: NCT01136460 Recruiting - Congenital Glaucoma Clinical Trials

Genetic Testing in Primary Congenital Glaucoma Patients

Start date: May 2006
Phase: N/A
Study type: Observational

Primary congenital glaucoma patients and their immediate relatives will undergo complete ophthalmic examination and an interview with a geneticist. A blood sample will be drown from all participants for DNA analysis. The CYP1B1 gene coding sequences will be screened for all individuals. If no mutation or only one heterozygous mutation will be found in the CYP1B1 gene, screening for MYOC gene mutations will be performed.

NCT ID: NCT01135862 Not yet recruiting - Clinical trials for Neurological Outcome

Platelet Administration To Patients With Traumatic Brain Injury Who Were Treated With Aspirin

Start date: June 2010
Phase: Phase 2
Study type: Interventional

Traumatic brain injury (TBI) is a devastating disease with high morbidity and mortality. Although not fully proved, it is commonly accepted that the morbidity and mortality and proportional to the extent of intracranial bleeds (i.e. - larger hemorrhages cause more injury than smaller ones). Aspirin is a commonly used antiaggregate drug that interferes with the clotting system. The antiaggregate effect may be neutralized by administration of platelets. Thus, potentially, patients receiving Aspirin and undergoing TBI, are at a higher risk for increasing an intracranial bleed. In this prospective study, the investigators randomize patients receiving aspirin that have a traumatic intracranial bleed to two groups, one - that will receive platelets, and the other that will not receive platelets. The primary end point of the study is to evaluate the effect of platelet administration of the enlargement of traumatic intracranial bleeds, and try and evaluate any clinical outcome differences between the two groups.

NCT ID: NCT01135784 Not yet recruiting - Chronic Migraine Clinical Trials

Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache

RZN
Start date: October 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to study MIGRA-ZEN RELIEF PLUS, an all-natural herbal dietary supplement product, with respect to alleviating and/or stopping migraine headache pain compared to a placebo when used prophylactically. This study will involve subjects suffering from chronic migraine headaches.

NCT ID: NCT01135745 Completed - Clinical trials for Obsessive Compulsive Disorder

Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF)

Start date: April 2010
Phase: Phase 4
Study type: Interventional

The purpose of the study is to monitor the safety and performance of Reclaim® Deep Brain Stimulation (DBS) Therapy in patients with chronic, severe, treatment-resistant Obsessive Compulsive Disorder.

NCT ID: NCT01135147 Not yet recruiting - Obesity Clinical Trials

Obesity and Obstructive Sleep Apnea (OSA) in Children

Start date: June 2010
Phase: N/A
Study type: Interventional

The goal of this research is to study the prevalence of sleep disordered breathing and associated morbidity in obese children and to examine the role of diet and physical activity in the treatment of sleep-disordered breathing in obese children.

NCT ID: NCT01134991 Terminated - Rosacea Clinical Trials

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

Start date: June 2010
Phase: Phase 2
Study type: Interventional

Acne rosacea is a chronic acneiform disorder affecting both the skin and the eye. It is a syndrome of undetermined etiology characterized by both vascular and papulopustular components involving the face and occasionally the neck and upper trunk. This is a pilot phase II study to evaluate the tolerability and safety and to monitor the clinical efficacy of Topical Minocycline Foam FXFM244 in moderate to severe Rosacea patients.

NCT ID: NCT01134926 Terminated - Clinical trials for Intra-uterine Residua

Non Surgical Management for Uterine Residua After Pregnancy Termination, Abortion or Delivery

Start date: June 2010
Phase: Phase 2
Study type: Interventional

The aim of the study is to find out whether conservative treatment - expectant management or medical therapy using misoprostol is beneficial in the case of uterine residua, and which treatment is better.